Deep learning models can help assess lung cancer diagnoses.

Published Date: 02 Mar 2023

A deep learning model called Sybil can predict future lung cancer risk based on a low-dose chest CT scan and identify people who are likely to benefit from regular treatment.

Read Full News

Latest News

Micro- and Nanoplastics: A Multiorgan Health Threat

Once present in the body, microplastics and nanoplastics can disrupt biological barriers and contribute to diseases impacting the gastrointestinal system and beyond.

Deep Dive: Is Bariatric Surgery Over?

New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

Nasal Strips: Fancy Tape or Medical Miracle?

Nasal strips flood your feed and promise better sleep. Dr Labos investigates whether nasal strips are worth the hype — or just a very convincing placebo.

Parkinson’s Treatment: Are Dopamine Agonists Fading?

New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor benefits against behavioral side effects.

Does Liso-Cel Offer Long-Term Survival Benefits in R/R LBCL?

Researchers report the 5-year survival outcomes with lisocabtagene maraleucel in heavily pretreated patients with relapsed or refractory LBCL in the TRANSCEND study.

Treat or Wait, New Data on Asymptomatic Kidney Stones

Actively treating asymptomatic kidney stones is associated with lower odds of later recurrence and the need for surgery.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Latest News

Once present in the body, microplastics and nanoplastics can disrupt biological barriers and contribute to diseases impacting the gastrointestinal system and beyond.

New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

Nasal strips flood your feed and promise better sleep. Dr Labos investigates whether nasal strips are worth the hype — or just a very convincing placebo.

New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor benefits against behavioral side effects.

Researchers report the 5-year survival outcomes with lisocabtagene maraleucel in heavily pretreated patients with relapsed or refractory LBCL in the TRANSCEND study.

Actively treating asymptomatic kidney stones is associated with lower odds of later recurrence and the need for surgery.

News All Time

CGRP May Lower Weather-Related Migraine Risk

Preventive treatment may blunt the impact of weather-related migraine triggers, in what investigators say is a first for migraine prevention.

Hyperbaric Oxygen Therapy Can Help in Refractory Colitis

Hyperbaric oxygen therapy is well tolerated in treatment-refractory ulcerative colitis and enhances clinical outcomes alongside improvement in bowel perfusion.

Ontario Docs to Screen Younger Patients for Colon Cancer

Ontario Health is poised to lower the colorectal cancer screening age to 45 years on July 1.

Primary Care Meets Artificial Intelligence

As AI continues to evolve, its integration into primary care is revolutionizing patient diagnosis, treatment, and management.

Canada Introduces Safe Social Media Act to Protect Children

Canada wants to make social media safer for children, but experts say key questions about how the law will actually work remain unanswered.

Do Involuntary Admissions Affect Clinicians’ Mental Health?

Researchers are examining how involuntary psychiatric admissions affect emergency clinicians, with findings expected to inform future support and training programs.

Heartburn Meds in Pregnancy Not Linked to Child GI Risk

Gastrointestinal reflux is common during pregnancy.

HSSIB Warns on Safety Gaps in Online Prescribing

NHS systems have failed to keep pace with the rapid growth of independent online prescribing, leaving clinicians without the information they need to prescribe safely, HSSIB warns.

The COVID Vaccine Study the CDC Doesn’t Want You to See

Higher-ups at the CDC blocked publication of a COVID vaccine effectiveness study, citing methodologic weaknesses. Now the study has been published for all to read.

Key Updates in Non-Small Cell Lung Cancer From ASCO 2026

Updates in NSCLC from ASCO 2026 include phase 3 results for selpercatinib, ivonescimab, and sac-TMT, plus emerging data for neladalkib in ALK+ disease and sunvozertinib in the frontline setting.

Family Docs Must Fight for Patients Beyond the Exam Room

AAFP President Sarah Nosal, MD, argues some of the greatest threats to patient health originate not in disease but in policy.

The Clinical Cost of Sunscreen Misinformation

We have to help patients understand that the known dangers of prolonged UV exposure is a much greater risk than unproven concerns.

Early Ultrasound Results May Predict Scar Pregnancy Outcomes

Among cases of cesarean scar ectopic pregnancies, about two thirds progress toward a live birth, but nearly half of the women require a hysterectomy around the time of delivery.

Who Better to Treat Menopause Than NPs?

Will nurse practitioners step into the demand for menopause education and management?

Vibrating Ingestible Capsule Flags Anorexia Relapse Risk

A vibrating capsule identifies subtle deficits in gut-brain signaling that are associated with relapse 6 months after weight restoration in anorexia nervosa.

FAST-Forward Trial Confirms 1-Week Breast RT at 10 Years

After a decade of follow-up, a 1-week RT regimen remains noninferior to standard treatment for early breast cancer, with similar rates of recurrence and long-term adverse events.